mRNA-based cancer vaccines: A novel approach to melanoma treatment
Advances in Immunology · 2025 · 117-162
DOI: 10.1016/bs.ai.2024.10.010 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Immunology, 2025. Verfasst von Pranav Kumar Prabhakar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. Electronic address: prabhak…. Hauptthemen laut MEDLINE: Melanoma, Cancer Vaccines, Immunotherapy, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. Electronic address: prabhakar.iitm@gmail.com.
- Parul Institute of Applied Sciences & Research and Development Cell, Parul University, Vadodara, Gujarat, India.
- School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Zitieren
APA
Prabhakar, P. K., Upadhyay, T. K., & Sahu, S. K. (2025). mRNA-based cancer vaccines: A novel approach to melanoma treatment. Advances in Immunology. https://doi.org/10.1016/bs.ai.2024.10.010
Vancouver
Prabhakar PK, Upadhyay TK, Sahu SK. mRNA-based cancer vaccines: A novel approach to melanoma treatment. Advances in Immunology. 2025. doi:10.1016/bs.ai.2024.10.010
BibTeX
@article{Prabhakar2025,
author = {Prabhakar, Pranav Kumar and Upadhyay, Tarun Kumar and Sahu, Sanjeev Kumar},
title = {mRNA-based cancer vaccines: A novel approach to melanoma treatment},
journal = {Advances in Immunology},
year = {2025},
doi = {10.1016/bs.ai.2024.10.010}
}
EUVIMED